New York State Common Retirement Fund’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.05M Buy
140,918
+3,000
+2% +$86.3K 0.01% 1146
2025
Q1
$4.63M Sell
137,918
-17,508
-11% -$587K 0.01% 1088
2024
Q4
$7.95M Buy
155,426
+7,735
+5% +$395K 0.01% 896
2024
Q3
$7.55M Sell
147,691
-19,051
-11% -$974K 0.01% 922
2024
Q2
$7.47M Buy
166,742
+14,250
+9% +$638K 0.01% 945
2024
Q1
$7.14M Buy
152,492
+124,767
+450% +$5.84M 0.01% 962
2023
Q4
$986K Buy
27,725
+44
+0.2% +$1.57K ﹤0.01% 1802
2023
Q3
$823K Buy
27,681
+4,942
+22% +$147K ﹤0.01% 1844
2023
Q2
$410K Sell
22,739
-6,025
-21% -$109K ﹤0.01% 2180
2023
Q1
$462K Sell
28,764
-10,356
-26% -$166K ﹤0.01% 2217
2022
Q4
$716K Sell
39,120
-28
-0.1% -$512 ﹤0.01% 2142
2022
Q3
$769K Buy
39,148
+5,156
+15% +$101K ﹤0.01% 2098
2022
Q2
$634K Buy
33,992
+2,571
+8% +$48K ﹤0.01% 2239
2022
Q1
$690K Buy
31,421
+5,104
+19% +$112K ﹤0.01% 2265
2021
Q4
$748K Sell
26,317
-70
-0.3% -$1.99K ﹤0.01% 2224
2021
Q3
$555K Sell
26,387
-5,135
-16% -$108K ﹤0.01% 2404
2021
Q2
$594K Buy
31,522
+6,722
+27% +$127K ﹤0.01% 2502
2021
Q1
$379K Hold
24,800
﹤0.01% 2567
2020
Q4
$350K Hold
24,800
﹤0.01% 2518
2020
Q3
$389K Hold
24,800
﹤0.01% 2336
2020
Q2
$434K Buy
24,800
+12,100
+95% +$212K ﹤0.01% 2290
2020
Q1
$187K Hold
12,700
﹤0.01% 2490
2019
Q4
$319K Hold
12,700
﹤0.01% 2515
2019
Q3
$191K Hold
12,700
﹤0.01% 2794
2019
Q2
$318K Buy
12,700
+8,600
+210% +$215K ﹤0.01% 2594
2019
Q1
$93K Hold
4,100
﹤0.01% 2970
2018
Q4
$123K Buy
+4,100
New +$123K ﹤0.01% 2902